Skip to main content
. 2016 Dec 28;22(48):10680–10686. doi: 10.3748/wjg.v22.i48.10680

Figure 2.

Figure 2

Computed tomography scan of patient 1 before and after 3 mo of olaparib (upper panel), and magnetic resonance imaging of liver metastasis of patient 2 before and after 3 mo of olaparib (lower panel).